Drug manufacturer, Genentech, announced the recall of Raptiva® in April 2009. This drug was used to treat Psoriasis and was linked to a life-threatening brain infection, progressive multifocal leukoencephalopathy (PML). Since Raptiva® was first introduced to the U.S. market, it has led to many